Early functional network alterations in asymptomatic elders at risk for Alzheimer’s disease
Abstract Amyloid-β (Aβ) deposition is known to starts decades before the onset of clinical symptoms of Alzheimer’s disease (AD), however, the detailed pathophysiological processes underlying this preclinical period are not well understood. This study aimed to investigate functional network alteratio...
Main Authors: | Akinori Nakamura, Pablo Cuesta, Takashi Kato, Yutaka Arahata, Kaori Iwata, Misako Yamagishi, Izumi Kuratsubo, Kimiko Kato, Masahiko Bundo, Kersten Diers, Alberto Fernández, Fernando Maestú, Kengo Ito |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2017-07-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-017-06876-8 |
Similar Items
-
The Importance of the Validation of M/EEG With Current Biomarkers in Alzheimer's Disease
by: Fernando Maestú, et al.
Published: (2019-02-01) -
Corrigendum: The Importance of the Validation of M/EEG With Current Biomarkers in Alzheimer's Disease
by: Fernando Maestú, et al.
Published: (2019-03-01) -
The Role of Magnetoencephalography in the Early Stages of Alzheimer’s Disease
by: David López-Sanz, et al.
Published: (2018-08-01) -
Atrophy rates in asymptomatic amyloidosis: implications for Alzheimer prevention trials.
by: K Abigail Andrews, et al.
Published: (2013-01-01) -
Diagnosis of Alzheimer’s Disease with [18F]PET in Mild and Asymptomatic Stages
by: Alexander Drzezga
Published: (2009-01-01)